Noxopharm Ltd banner

Noxopharm Ltd
ASX:NOX

Watchlist Manager
Noxopharm Ltd Logo
Noxopharm Ltd
ASX:NOX
Watchlist
Price: 0.062 AUD -8.82%
Market Cap: AU$18.1m

Income Statement

Earnings Waterfall
Noxopharm Ltd

Income Statement
Noxopharm Ltd

Rotate your device to view
Income Statement
Currency: AUD
Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Revenue
Revenue
3
N/A
4
+14%
4
+10%
8
+92%
6
-30%
6
-2%
6
+9%
5
-13%
7
+29%
6
-13%
4
-36%
2
-38%
2
-2%
3
+20%
Operating Income
Operating Expenses
(13)
(16)
(18)
(16)
(14)
(20)
(19)
(15)
(18)
(17)
(11)
(7)
(7)
(8)
Selling, General & Administrative
(8)
(9)
(11)
(9)
(7)
(7)
(6)
(7)
(7)
(6)
(5)
(4)
(4)
(4)
Research & Development
(5)
(6)
(7)
(7)
(7)
(13)
(13)
(8)
(10)
(11)
(6)
(3)
(3)
(4)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Operating Income
(10)
N/A
(12)
-19%
(14)
-19%
(8)
+42%
(8)
-2%
(15)
-77%
(13)
+10%
(10)
+25%
(11)
-9%
(11)
+0%
(7)
+32%
(5)
+37%
(5)
0%
(5)
-17%
Pre-Tax Income
Interest Income Expense
(0)
(1)
(2)
7
8
5
2
(9)
(5)
(4)
(5)
1
2
0
Non-Reccuring Items
(1)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(11)
N/A
(13)
-17%
(16)
-26%
(1)
+94%
(0)
+96%
(9)
-20 857%
(11)
-20%
(19)
-66%
(15)
+17%
(15)
+3%
(12)
+19%
(4)
+70%
(2)
+35%
(5)
-111%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(11)
(13)
(16)
(1)
(0)
(9)
(11)
(19)
(15)
(15)
(12)
(4)
(2)
(5)
Income to Minority Interest
1
1
2
1
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(10)
N/A
(11)
-13%
(14)
-22%
(0)
+98%
(0)
+84%
(9)
-20 857%
(11)
-20%
(19)
-66%
(15)
+17%
(15)
+3%
(12)
+19%
(4)
+70%
(2)
+35%
(5)
-111%
EPS (Diluted)
-0.07
N/A
-0.08
-14%
-0.1
-25%
0
N/A
0.02
N/A
-0.04
N/A
-0.04
N/A
-0.06
-50%
-0.05
+17%
-0.05
N/A
-0.04
+20%
-0.01
+75%
-0.01
N/A
-0.02
-100%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett